EYES logo

EYES Working Capital

EYES Annual Working Capital

$68.05 M
+$68.91 M+7984.70%

31 December 2021

EYES Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EYES Quarterly Working Capital

$54.80 M
-$3.03 M-5.25%

30 June 2022

EYES Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EYES Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7984.7%-23.7%
3 y3 years+3265.2%+171.2%
5 y5 years+938.9%+215.9%

EYES Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat high-23.7%

Second Sight Medical Products Working Capital History

DateAnnualQuarterly
June 2022
-
$54.80 M(-5.2%)
Mar 2022
-
$57.83 M(-15.0%)
Dec 2021
$68.05 M(-7984.7%)
$68.05 M(-1.8%)
Sept 2021
-
$69.30 M(-3.4%)
June 2021
-
$71.78 M(+247.1%)
Mar 2021
-
$20.68 M(-2496.4%)
Dec 2020
-$863.00 K(-114.0%)
-$863.00 K(-362.3%)
Sept 2020
-
$329.00 K(-82.3%)
June 2020
-
$1.86 M(-219.4%)
Mar 2020
-
-$1.56 M(-125.3%)
Dec 2019
$6.15 M(+204.2%)
$6.15 M(-53.3%)
Sept 2019
-
$13.17 M(-34.8%)
June 2019
-
$20.21 M(-26.8%)
Mar 2019
-
$27.60 M(+1265.1%)
Dec 2018
$2.02 M(-69.1%)
$2.02 M(-26.4%)
Sept 2018
-
$2.75 M(-48.0%)
June 2018
-
$5.29 M(+136.7%)
Mar 2018
-
$2.23 M(-65.9%)
DateAnnualQuarterly
Dec 2017
$6.55 M(-31.9%)
$6.55 M(-43.6%)
Sept 2017
-
$11.61 M(-33.1%)
June 2017
-
$17.34 M(-24.1%)
Mar 2017
-
$22.85 M(+137.6%)
Dec 2016
$9.62 M(-48.8%)
$9.62 M(-49.4%)
Sept 2016
-
$19.02 M(-28.3%)
June 2016
-
$26.51 M(+83.4%)
Mar 2016
-
$14.46 M(-23.0%)
Dec 2015
$18.78 M(-44.0%)
$18.78 M(-18.6%)
Sept 2015
-
$23.08 M(-14.2%)
June 2015
-
$26.91 M(-8.5%)
Mar 2015
-
$29.40 M(-12.3%)
Dec 2014
$33.52 M(+268.2%)
$33.52 M(+663.9%)
Sept 2014
-
$4.39 M(-42.9%)
June 2014
-
$7.68 M(+30.6%)
Mar 2014
-
$5.88 M(-35.4%)
Dec 2013
$9.10 M(+112.9%)
$9.10 M
Dec 2012
$4.28 M
-

FAQ

  • What is Second Sight Medical Products annual working capital?
  • What is the all time high annual working capital for Second Sight Medical Products?
  • What is Second Sight Medical Products annual working capital year-on-year change?
  • What is Second Sight Medical Products quarterly working capital?
  • What is the all time high quarterly working capital for Second Sight Medical Products?
  • What is Second Sight Medical Products quarterly working capital year-on-year change?

What is Second Sight Medical Products annual working capital?

The current annual working capital of EYES is $68.05 M

What is the all time high annual working capital for Second Sight Medical Products?

Second Sight Medical Products all-time high annual working capital is $68.05 M

What is Second Sight Medical Products annual working capital year-on-year change?

Over the past year, EYES annual working capital has changed by +$68.91 M (+7984.70%)

What is Second Sight Medical Products quarterly working capital?

The current quarterly working capital of EYES is $54.80 M

What is the all time high quarterly working capital for Second Sight Medical Products?

Second Sight Medical Products all-time high quarterly working capital is $71.78 M

What is Second Sight Medical Products quarterly working capital year-on-year change?

Over the past year, EYES quarterly working capital has changed by -$16.98 M (-23.66%)